Biocon already sells a generic version of an older weight-loss drug (Liraglutide) in the UK and has signed a deal to distribute generic semaglutide in Brazil
Last year, a study revealed people with diabetes who use the drugs could face double the risk of developing age-related macular degeneration, while reports based on adverse event reporting systems and matched cohort studies have suggested some GLP-1 medications have the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy
Your semaglutide practitioner will evaluate your medical background, existing treatment protocols, lifestyle habits, and aspirations to design a customized plan addressing your needs
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated a 15% average body weight reduction in clinical trials when used for weight management
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models
Altenkirch H, Stoltenburg-Didinger G, Wagner HM, et al